Evidence map›Paper›PMID 33803845›Full record

ArticleCells2021

Identification of Genetic Modifiers of TDP-43: Inflammatory Activation of Astrocytes for Neuroinflammation.

Jae-Hong Kim, Md Habibur Rahman, Donghwi Park, Myungjin Jo, Hyung-Jun Kim, Kyoungho Suk

Open access · goldAbstract read
In one paragraph

Article in Cells, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
1.7field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 23 citations in OpenAlex.

  1. Article
  2. Article
  3. ALS-FTD-linked CCNFJournal of neuroinflammation · 2026
    Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Identifying and Diagnosing TDP-43 Neurodegenerative Diseases in Psychiatry.The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry · 2024
    Review
  12. Article
  13. Article
  14. Emerging Therapies and Novel Targets for TDP-43 Proteinopathy in ALS/FTD.Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics · 2022
    Review
  15. Article
  16. Article
  17. Review
  18. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Jae-Hong KimDepartment of Pharmacology, School of Medicine, Kyungpook National University, Daegu 41944, Korea.
Md Habibur RahmanDepartment of Pharmacology, School of Medicine, Kyungpook National University, Daegu 41944, Korea.
Donghwi ParkDepartment of Pharmacology, School of Medicine, Kyungpook National University, Daegu 41944, Korea.
Myungjin JoDepartment of Pharmacology, School of Medicine, Kyungpook National University, Daegu 41944, Korea.
Hyung-Jun KimDementia Research Group, Korea Brain Research Institute (KBRI), Daegu 41062, Korea.
Kyoungho SukDepartment of Pharmacology, School of Medicine, Kyungpook National University, Daegu 41944, Korea.ORCID 0000-0002-9555-4203
Kyungpook National University · KRKorea Brain Research Institute · KR

Funding

National Research Foundation (NRF), which is funded by the Korean government 2018R1A2A1A05077118, 2016M3C7A1904148, NRF-2017R1A5A2015391, and NRF-2020M3E5D9079764
6 · The paper itself

Abstract

Transactive response DNA-binding protein 43 (TDP-43) is a ubiquitously expressed DNA/RNA-binding protein linked to amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD). TDP-43 has been implicated in numerous aspects of the mRNA life cycle, as well as in cell toxicity and neuroinflammation. In this study, we used the toxicity of the TDP-43 expression in

Indexed as

Amyotrophic Lateral SclerosisAstrocytesDNA-Binding ProteinsFrontotemporal DementiaHumansInflammationMutationNeurogliaDNA-Binding ProteinsTARDBP protein, humanamyotrophic lateral sclerosisastrocytegenetic interactionglianeuroinflammationTDP-43

Identifiers

PMID33803845
PMCPMC8003223
OpenAlexW3138801107

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.